-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

731. Autologous Transplantation: Clinical and Epidemiological: Poster II

Symposia: Autologous Transplantation: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 11, 2022: 6:00 PM-8:00 PM
Hall D (Ernest N. Morial Convention Center)

Sandeep Anand Padala, MD1*, Anusha Vakiti, MBBS2, Wendy Bollag, PhD2*, Jennifer Waller, PhD2*, Mufaddal Kheda, MD3*, Stephanie L Baer, MD4*, Ravindra Kolhe, MD, PhD5*, Mohammad A. H. Mian, PhD6*, Anand P. Jillella, MD7, Jorge E. Cortes, MD8 and Vamsi Kota, MD9

1Department of Hematology Oncology, Augusta University Medical Center, Augusta, GA
2Augusta University, Augusta, GA
3Southwest Georgia Nephrology, Albany, GA
4Charlie Norwood VA medical Center, Augusta, GA
5Department of Pathology, Augusta University, Augusta, GA
6Division of Hematology/Oncology, Georgia Cancer Center at Augusta University, Martinez, GA
7Division of Hematology/Oncology, Georgia Cancer Center at Augusta University, Augusta, GA
8Georgia Cancer Center, Augusta, GA
9Department of Medicine: Hematology and Oncology, Medical College of Georgia, Augusta University, Augusta, GA

Edvan De Queiroz Crusoe, MD, PhD, MSc1,2,3, Joanna Leal, MD4*, Juliana Andrade Santos, MD5,6*, Herbert Henrique de Melo Santos, MD7*, Allan de souza Santos, BS8*, Larissa Ferreira Lucas, MD9*, Alessandro de M. Almeida, MD10,11, Marcos Chaves, MD12*, Daniela Dourado Dutra, MD5*, Vania T. M. Hungria, MD, PhD13,14, Marco Aurelio Salvino, PhD2,15 and Maria da Gloria B. Arruda, MD, PhD16*

1Rua Dra Doutro Vianna S/n, Universidade Federal da Bahia- Hospital Universitario, Salvador, Brazil
2Hospital Universitário Professor Edgard Santos - Federal University of Bahia (HUPES - UFBA), Salvador, Brazil
3Hematology department- D'or Oncologia, Clinica CEHON Rede D'or Oncologia, Salvador, Brazil
4Hematology, Hematology Rede D'or oncologia, salvador, Brazil
5Federal University of Bahia, Salvador, Brazil
6Hematology, Clinica CEHON Rede D'or oncologia, Salvador, Brazil
7Immunology, molecullar and Cytometry Laboratory- ICS, Federal University of Bahia, Salvador, Brazil
8Immunology, mollecular and cytometry Laboratory- ICS, Federal University of Bahia, Salvador, Brazil
9Hematology, CLinica CEHON Rede D'or Oncologia, salvador, Brazil
10Stem Cell Transplant Unit, Federal University of Bahia, Salvador, Brazil
11Hematology and Bone Marrow Unit, Rede D´or Oncologia, salvador, Brazil
12Federal University of Bahia- Hematology and Hemotheraphy, salvador, Brazil
13Hematology, Santa Casa Medical School, São Paulo, Brazil
14Department of Hematology and Oncology, Clínica São Germano, Sao Paulo, Brazil
15Hematology and Bone Marrow Transplantation UNIT, Rede D'or Oncologia, Salvador, Brazil
16Hematology, Clinica CEHON Rede D'or Oncologia, salvador, Brazil

Paul Szabolcs, MD1, Evelyn Garchar, MS2*, Xiaohua Chen, MD PhD2, Anwesha Sanyal, PhD3*, Giffin Werner, MS3*, Jessie L. Barnum, MD2 and Kathryn Torok, MD4*

1Division of Blood and Marrow Transplantation and Cellular Therapies, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA
2Division of Blood and Marrow Transplantation and Cellular Therapy, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA
3Division of Pediatric Rheumatology, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA
4Division of Rheumatology, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA

Hongye Gao, M.D.*, Weiping Liu, M.D.*, Yuqin Song, MD and Jun Zhu, PhD

Department of Lymphoma, Peking University Cancer Hospital & Institute, Beijing, China

Uros Markovic, MD1,2*, Giulio Antonio Milone, MD1,3*, Daniela Carco4*, Valeria Iachelli4*, Nunziatina Laura Parrinello, PhD5,6*, Paola Scire1*, Gabriella Amato1*, Federica Galbo1*, Giuseppe Milone, MD2, Emanuele Martorana7* and Gaetano Moschetti, MD8*

1Onco-Hematology and BMT Unit, Mediterranean Institute of Oncology, Viagrande, Italy
2Hematology and BMT Unit, Azienda Ospedaliero Universitaria Policlinico "G.Rodolico-San Marco", Catania, Italy
3Hematology and BMT Unit, Azienda Policlinico Vittorio Emanuele, Catania, Italy
4Unità Operativa di Laboratorio Analisi Chimco Cliniche, Mediterranean Institute of Oncology, Viagrande, Italy
5Division of Hematology and BMT, Azienda Ospedaliero Universitaria Policlinico "G.Rodolico-San Marco", Catania, Italy
6A.O.U. Policlinico "Vittorio Emanuele", University of Catania, Catania, CA, ITA
7IOM (Mediterranean Institute of Oncology) Ricerca, Viagrande, Italy
8Oncohematology and BMT Unit, Mediterranean Institute of Oncology, VIAGRANDE, Italy

Jessie L Barnum, MD1, Kathryn Torok, MD2*, Franziska Rosser, MD3*, Nicole Hogue, PA-C1*, Shawna Mcintyre, BSN RN1*, Haley Havrilla, MS2*, Vickie Vandergrift, RN, BSN, CPN2*, Kirsten Rose-Felker, MD4*, Vibha Sood, MD5*, Adam Olson, MD6* and Paul Szabolcs, MD1

1Division of Blood and Marrow Transplantation and Cellular Therapies, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA
2Division of Rheumatology, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA
3Division of Pulmonary Medicine, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA
4Division of Cardiology, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA
5Division of Gastroenterology, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA
6Division of Radiation Oncology, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA

Eliezer Tomas Tomas Gomez Gomez, PhD1,2,3*, David Gomez Almaguer, MD4*, Cesar Homero Gutierrez-Aguirre, PhD5,6,7,8*, Perla R. R. Colunga-Pedraza, MD9,10, Luz Tarin-Arzaga, MD11*, Jose Carlos Jaime, MD, PhD12,13*, Edgar Ulises Coronado, MD14*, Fernando De La Garza, MD9*, Estefania Guadarrama Rendon, MD14* and Santiago Calzada Davila, MD14*

1Servicio de Hematología, Universidad Autonoma de Nuevo Leon, Hospital Universitario "Dr. José Eleuterio Gonzalez", Guadalupe, HI, Mexico
2Universidad Autonoma de Nuevo Leon, Hospital Universitario "Dr. José Eleuterio Gonzalez", Servicio de Hematología, Monterrey, NL, Mexico
3Universidad Autonoma de Nuevo Leon, Hospital Universitario "Dr. José Eleuterio Gonzalez", Servicio de Hematología, Monterrey, NL, Mexico, Monterrey, HI, MEX
4Gomez Almaguer Clinica de Hematologia, Monterrey, Mexico
5Universidad Autonoma de Nuevo Leon, Hospital Universitario "Dr. José Eleuterio Gonzalez", Servicio de Hematología, Monterrey, Mexico
6Universidad Autónoma de Nuevo León, Monterrey, Mexico
7Universidad Autonoma de Nuevo Leon, Monterrey, Mexico
8Hematology, Hospital Universitario Dr. Jose Eleuterio Gonzalez, Monterrey, Mexico
9Servicio de Hematología, Universidad Autonoma de Nuevo Leon, Hospital Universitario "Dr. José Eleuterio Gonzalez", Monterrey, Mexico
10Servicio de Hematología, Universidad Autónoma de Nuevo León. Facultad de Medicina y Hospital Universitario “Dr. José Eleuterio González”, Monterrey, NL, Mexico
11Servicio de Hematología, Universidad Autónoma de Nuevo León. Facultad de Medicina y Hospital Universitario “Dr. José Eleuterio González”, Monterrey, YU, MEX
12Universidad Autónoma de Nuevo León, NUEVO LEON, Mexico
13Hematology, Universidad Autónoma de Nuevo León, Hospital Universitario "Dr José Eleuterio González", Monterrey, Mexico
14Hematologia UANL, Hospital Universitario UANL, monterrey nuevo leon, Mexico

Aude Collignon, MD1,2*, Benjamin Bouchacourt1*, Patrick Sfumato3*, Gabriel Brisou, MD, PhD2*, Jean Marc Schiano de Collela, MD4*, Luca Inchiappa, MD2*, Boris Calmels, PharmD-PhD5*, Claude Lemarié4*, Tibaulth Reichert, MD6*, Samia Harbi, MD4*, Raynier Devillier4*, Anne Calleja3*, Thomas Pagliardini, MD4*, Guillaume Morel3*, Angela Granata7*, Norbert Vey, MD8, Reda Bouabdallah9*, Didier Blaise, MD, PhD2, Christian Chabannon, MD-PhD5, Robin Noel, MD2* and Catalina Montes De Oca, MD2,4*

1Onco-Hematology Department, Paoli-Calmette Cancer Institute, Marseille, France
2Hematology Department, Institut Paoli-Calmettes, Marseille, France
3INSTITUT PAOLI CALMETTES, MARSEILLE, France
4Institut Paoli Calmettes, Marseille, France
5Cell Therapy Facility, Institut Paoli-Calmettes, Marseille, France
6INSTITUT PAOLI CALMETTES, INSTITUT PAOLI CALMETTES, MARSEILLE, France
7Apheresis Facility, Institut Paoli Calmettes, Marseille, France
8Institut Paoli-Calmettes, Aix-Marseille University, UM 105, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS UMR7258, Marseille, France
9HOPITAL PRIVE DE PROVENCE, MARSEILLE, France

Rongli Zhang1*, Mengnan Lyu1*, Yi He2*, Donglin Yang1*, Aiming Pang2*, Jialin Wei2*, Qiaoling Ma2*, Weihua Zhai3*, Xin Chen1*, Guixin Zhang1*, Sizhou Feng1*, Mingzhe Han1* and Erlie Jiang1*

1National Clinical Research Center for Blood Diseases, State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
2State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, CAMS & PUMC, Tianjin, China
3State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical Colleg, Tianjin, China

Matthew Gromowsky1*, Zhubin Gahvari, MD2, Robin High, MBA, MA3*, Natalie Callander, MD2,4 and Christopher D'Angelo, MD5*

1University of Nebraska Medicine, Omaha, NE
2University of Wisconsin, Madison, WI
3Department of Biostatistics, University of Nebraska Medical Center, Omaha, NE
4Division of Hematology/Oncology, Department of Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI
5Division of Hematology & Oncology, Department of Internal Medicine, University of Nebraska Medical Center- Fred and Pamela Buffett Cancer Center, Omaha, NE

Jessica L. Bazin, MBChB, MSC, MRCP, FRCPath1,2*, Yasser Abou Mourad, MD, FRCPC, FACP1,2, Donna L. Forrest, MD, FRCPC1,2, Kevin A Hay, MD, MSc, FRCPC2,3,4,5, Florian Kuchenbauer, MD PhD1,2,4, Stephen H. Nantel, MD, FRCPC1,2, Sujaatha Narayanan, MBBS, MRCP, MRCPath1,2*, Thomas J. Nevill, MD, FRCPC1,2, Maryse Power, MB, FRCPI, FRCPath1,2, Judith A Rodrigo, MD, FRCPC1,2*, Claudie Roy, MD, FRCPC1,2*, David Sanford, MD1,2, Kevin Song, MD, FRCPC1,2, Ryan J. Stubbins, MD, MSc, FRCPC1,2, Heather J. Sutherland, MD, PhD, FRCPC1,2, Cynthia L. Toze, MD, FRCPC, MSc1,2*, Jennifer White, MD, MSc, FRCPC1,2* and Shanee Chung, MBChB, FRACP, FRCPA1,2

1The Leukemia/Bone Marrow Transplant Program of British Columbia, British Columbia Cancer Agency, Vancouver, BC, Canada
2Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada
3The Leukemia/Bone Marrow Transplant Program of British Columbia, Vancouver General Hospital, Vancouver, BC, Canada
4Terry Fox Laboratory, British Columbia Cancer Research Institute, Vancouver, BC, Canada
5Clinical Cell Therapy Laboratory, British Columbia Cancer Research Institute, Vancouver, BC, Canada

*signifies non-member of ASH